Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q45233225)
Watch
English
Evolution of FOLFOX regimens in the treatment of advanced colorectal cancer.
scientific article published in January 2005
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15663831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15663831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
title
Evolution of FOLFOX regimens in the treatment of advanced colorectal cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15663831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15663831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
main subject
colorectal cancer
1 reference
based on heuristic
inferred from title
author name string
G Kesava Reddy
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15663831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15663831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
Angelia D Gibson
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15663831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15663831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
Nancy Price
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15663831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15663831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
language of work or name
English
0 references
publication date
1 January 2005
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15663831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15663831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
published in
Clinical Colorectal Cancer
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15663831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15663831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
volume
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15663831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15663831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
issue
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15663831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15663831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
page(s)
296-299
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15663831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15663831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
cites work
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1533-0028%2811%2970130-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I study of oxaliplatin in patients with advanced cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1533-0028%2811%2970130-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1533-0028%2811%2970130-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systemic infusion versus bolus chemotherapy with 5-fluorouracil in measurable metastatic colorectal cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1533-0028%2811%2970130-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1533-0028%2811%2970130-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1533-0028%2811%2970130-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1533-0028%2811%2970130-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1533-0028%2811%2970130-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1533-0028%2811%2970130-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1533-0028%2811%2970130-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1533-0028%2811%2970130-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1533-0028%2811%2970130-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1533-0028%2811%2970130-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1533-0028%2811%2970130-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1533-0028(11)70130-X
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15663831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15663831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
PubMed publication ID
15663831
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15663831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15663831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit